tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Genix Pharmaceuticals Launches Private Placement to Fund ARMD Eyedrops Project

Story Highlights
Genix Pharmaceuticals Launches Private Placement to Fund ARMD Eyedrops Project

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Genix Pharmaceuticals ( (TSE:GENX) ) has provided an announcement.

Genix Pharmaceuticals has announced a non-brokered private placement to raise up to $100,000 through the sale of 2,000,000 units, each comprising one common share and one warrant. The funds will support the company’s Age Related Macular Degeneration Eyedrops project and general working capital. This move is expected to involve certain company insiders and requires regulatory approvals, highlighting the company’s strategic efforts to advance its product pipeline and strengthen its financial position.

More about Genix Pharmaceuticals

Genix Pharmaceuticals Corporation is a Canadian company specializing in ophthalmic drugs. It focuses on the research, development, manufacture, licensing, and sales of innovative prescription and over-the-counter ophthalmological products, catering to the growing needs of consumers worldwide, particularly aging baby boomers. The company has three products pending Health Canada approval.

Average Trading Volume: 21,307

Technical Sentiment Signal: Sell

Current Market Cap: C$2.07M

For detailed information about GENX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1